<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antiendothelial cell antibodies (AECAs) are commonly detectable in diseases associated with vascular injury, including <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE), systemic <z:mp ids='MP_0000612'>sclerosis</z:mp>, <z:e sem="disease" ids="C0039263" disease_type="Disease or Syndrome" abbrv="">Takayasu</z:e> <z:hpo ids='HP_0012089'>arteritis</z:hpo>, Wegener <z:hpo ids='HP_0002955'>granulomatosis</z:hpo>, <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et syndrome, and transplant <z:hpo ids='HP_0002634'>arteriosclerosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we explore the hypothesis that these antibodies might augment polymorphonuclear leukocyte (PMN) <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to endothelium in <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Initially, we established that a mouse IgG mAb bound to endothelial cells (ECs) significantly increased PMN <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to cytokine-stimulated endothelium in an FcgammaRIIa-dependent manner </plain></SENT>
<SENT sid="3" pm="."><plain>Neutralizing antibodies, and adenoviral transduction of resting ECs, demonstrated that the combination of E-selectin, CXCR1/2, and beta(2) integrins is both necessary and sufficient for this process </plain></SENT>
<SENT sid="4" pm="."><plain>We observed an identical mechanism using AECA IgG isolated directly from patients with SLE </plain></SENT>
<SENT sid="5" pm="."><plain>Assembled immune complexes also enhanced PMN <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to endothelium, but, in contrast to <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> because of AECAs, this process did not require CXCR1/2, was not inhibited by <z:e sem="disease" ids="C0043167" disease_type="Disease or Syndrome" abbrv="">pertussis</z:e> toxin, and was FcgammaRIIIb rather than FcgammaRIIa dependent </plain></SENT>
<SENT sid="6" pm="."><plain>These data are the first to demonstrate separate nonredundant FcgammaRIIa and FcgammaRIIIb-mediated mechanisms by which EC-bound monomeric IgG and assembled immune complexes amplify leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> under dynamic conditions </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, the observation that FcgammaRIIa and CXCR1/2 cooperate to enhance PMN recruitment in the presence of AECAs suggests a mechanism whereby AECAs may augment tissue injury during <z:mp ids='MP_0001845'>inflammatory responses</z:mp> </plain></SENT>
</text></document>